Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-26 @ 5:53 PM
Study NCT ID:
NCT04448834
Status:
WITHDRAWN
Last Update Posted:
2022-03-02
First Post:
2020-06-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL
Sponsor:
Dorothy Sipkins, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-22
First Submit QC Date:
None
Study First Post Date:
2020-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-14
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL